AmpliFAST - PCR in the Palm of Your Hand

​

AmpliFast technology for in home diagnostics. Cassette driven diagnostic kit for fast and early detection of infectious diseases. 

Invention Summary:

There is a need to develop easy-to-use diagnostic kits based on newly discovered enzymes that enable nucleic acid amplification.

Rutgers researchers have developed a new technology that utilizes novel proprietary enzymes designed to amplify nucleic acids at room temperature, facilitating the development of easy-to-use diagnostic paper strip kits for at-home testing. This isothermal molecular technology achieves the same performance without lab processes for use anywhere. This technology has been validated on Lyme disease detection, it extends applicability to a broad range of tick-borne pathogens, infectious diseases, and cancer diagnostics.

Market Applications:

• Development of at-home diagnostic kits for infectious diseases and cancer
• Agricultural pathogen detection
• Food safety testing
• Biodefense monitoring

Advantages:

• Underlying chemistry allows development of consumer-facing products
• Rapid testing methods
• Cost-effective and affordable
• Broad applicability across multiple diseases
• High sensitivity and specificity for accurate detection

Intellectual Property & Development Status: PCT application filed. Patent pending. Available for licensing and/or research collaboration. For any business development and other collaborative partnerships, contact:  marketingbd@research.rutgers.edu